Safety, Tolerability, PK, PD, Immunogenicity and Efficacy of TWP-102 in Patients With Advanced Malignancies.

NCT05024305 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignancies

Interventions

DRUG: TWP-102 injection

Sponsor

Shandong TheraWisdom Biopharma Co., Ltd.